 |
 |
 |
|
FOSTEMSAVIR EXPOSURE-RESPONSE RELATIONSHIPS IN TREATMENT EXPERIENCED HIV PATIENTS
|
|
|
Glasgow 2020 Oct 5-8 virtual
Reported by Jules Levin
Ridhi Parasrampuria,1 Navin Goyal,1 Katy Moore,2 Peter Ackerman,3 Cyril C. Llamoso,3 Keith Barker,4 Mindy Magee1
1GlaxoSmithKline, Collegeville, PA, USA; 2ViiV Healthcare, Research Triangle Park, NC, USA;
3ViiV Healthcare, Branford, CT, USA; 4GlaxoSmithKline, Uxbridge, UK Ridhi Parasrampuria; ridhi.x.parasrampuria@gsk.com




|
|
|
 |
 |
|
|